Jabil Inc vs Medtronic PLC — how do they compare? Jabil Inc trades at $362 (market cap $35.27B), while Medtronic PLC trades at $90.48 (market cap $114.45B). The key difference: Medtronic PLC is far larger — about 3.2× Jabil Inc's market cap, and Medtronic PLC pays the higher dividend (3.22%). Which is the better fit depends on your goals.
| JBL | MDT | |
|---|---|---|
Market Cap | $35.27B | $114.45B |
Sector | Technology | Health |
52-Week High | $385.50 | $105.35 |
52-Week Low | $192.49 | $73.75 |
Enterprise Value | $37.81B | $133.19B |
Dividend Yield | 0.1% | 3.22% |
Signals from Pluang's Aura AI — not financial advice
Jabil trades at $341.22, down 1.0% today but maintains strong momentum with a bullish technical outlook and consistent earnings beats. The stock shows robust fundamentals with revenue growth from $29.8B in 2025 to $33.6B projected for 2026, supported by AI infrastructure demand and diversified operations. Recent news highlights Jabil's 31.6% six-month surge and strategic expansion with a new logistics hub in Penang.
Jabil presents a compelling growth story driven by AI and manufacturing excellence, with analyst consensus pointing to significant upside (target $448.29). However, elevated valuation multiples (P/E 42.13) and competitive pressures in the EMS sector warrant caution. The stock's technical strength and fundamental momentum support a positive outlook, though investors should monitor execution risks and market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →